Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Child and Adolescent Psychopharmacology|December 29, 2010
The importance of taking a history of over-the-counter medication use: a brief review and case illustration of "PRN" antihistamine dependence in a hospitalized adolescentBarbara Gracious, Naomi Abe, Jane SundbergHCA Healthcare Journal of Medicine|January 10, 2025
A Case of Xylazine-Induced Necrotic Skin Ulcerations in an IV-Drug User in FloridaMark Zaki, Cynthia Dillon, Anjali Patel, et al.Cureus|August 26, 2024
Refractory Homicidal Ideation in a Young Adult Male With High-Functioning Autism Spectrum Disorder and SchizophreniaNatasha R Patel, Numa Rehmani, Rachel Utter, et al.Frontiers in Psychiatry|May 28, 2021
Excited Catatonia in Autism Spectrum Disorder: A Case SeriesNora Kathleen Burns, Kathleen Grissett, Marc Macaluso, et al.Journal of Child and Adolescent Psychopharmacology|October 22, 2013
Nutritional and safety outcomes from an open-label micronutrient intervention for pediatric bipolar spectrum disordersElisabeth A Frazier, Barbara Gracious, L Eugene Arnold, et al.Journal of the American Academy of Child and Adolescent Psychiatry|September 19, 2020
Elements of the New ConversationL Eugene Arnold, Jeanette Johnstone, Barbara Gracious, et al.Early Human Development|September 25, 2017
Omega-3 and -6 fatty acid supplementation and sensory processing in toddlers with ASD symptomology born preterm: A randomized controlled trialKelly M Boone, Barbara Gracious, Mark A Klebanoff, et al.Current Medical Research and Opinion|June 30, 2022
Paediatric adverse event rating scale: a measure of safety or efficacy? Novel analysis from the MADDY studyBrenda M Y Leung, Priya Srikanth, Barbara Gracious, et al.Journal of Child and Adolescent Psychopharmacology|February 4, 2017
Omega-3 Fatty Acid Plasma Levels Before and After Supplementation: Correlations with Mood and Clinical Outcomes in the Omega-3 and Therapy StudiesL Eugene Arnold, Andrea S Young, Martha A Belury, et al.Contemporary Clinical Trials Communications|November 26, 2019
Rationale and design of an international randomized placebo-controlled trial of a 36-ingredient micronutrient supplement for children with ADHD and irritable mood: The Micronutrients for ADHD in Youth (MADDY) studyJeanette M Johnstone, Brenda Leung, Barbara Gracious, et al.Pageof 2